Perrigo Company plc (PRGO)

USD 25.44

(-3.67%)

Net Income Summary of Perrigo Company plc

  • Perrigo Company plc's latest annual net income in 2023 was -12.7 Million USD , up 90.3% from previous year.
  • Perrigo Company plc's latest quarterly net income in 2024 Q2 was -105.7 Million USD , down -2678.05% from previous quarter.
  • Perrigo Company plc reported an annual net income of -130.9 Million USD in 2022, down 0.0% from previous year.
  • Perrigo Company plc reported an annual net income of -130.9 Million USD in 2021, up 19.5% from previous year.
  • Perrigo Company plc reported a quarterly net income of 4.09 Million USD for 2024 Q1, up 112.69% from previous quarter.
  • Perrigo Company plc reported a quarterly net income of -1.1 Million USD for 2023 Q1, up 91.34% from previous quarter.

Annual Net Income Chart of Perrigo Company plc (2023 - 1992)

Historical Annual Net Income of Perrigo Company plc (2023 - 1992)

Year Net Income Net Income Growth
2023 -12.7 Million USD 90.3%
2022 -130.9 Million USD 0.0%
2021 -130.9 Million USD 19.5%
2020 -162.6 Million USD -211.29%
2019 146.1 Million USD 11.53%
2018 131 Million USD 9.53%
2017 119.6 Million USD 102.98%
2016 -4.01 Billion USD -3237.45%
2015 127.9 Million USD -37.7%
2014 205.3 Million USD -53.54%
2013 441.9 Million USD 10.03%
2012 401.61 Million USD 18.4%
2011 339.19 Million USD 52.42%
2010 222.54 Million USD 54.49%
2009 144.04 Million USD 6.1%
2008 135.77 Million USD 83.98%
2007 73.79 Million USD 3.36%
2006 71.4 Million USD 120.23%
2005 -352.98 Million USD -538.12%
2004 80.56 Million USD 49.07%
2003 54.04 Million USD 7.67%
2002 50.19 Million USD 81.5%
2001 27.65 Million USD 43.31%
2000 19.29 Million USD 1186.53%
1999 1.5 Million USD 102.91%
1998 -51.6 Million USD -214.67%
1997 45 Million USD 13.07%
1996 39.8 Million USD -10.36%
1995 44.4 Million USD -18.98%
1994 54.8 Million USD 22.87%
1993 44.6 Million USD 55.94%
1992 28.6 Million USD 0.0%

Peer Net Income Comparison of Perrigo Company plc

Name Net Income Net Income Difference
Amneal Pharmaceuticals, Inc. -83.99 Million USD 84.88%
Bausch Health Companies Inc. -592 Million USD 97.855%
Catalent, Inc. -1.04 Billion USD 98.782%
Emergent BioSolutions Inc. -760.5 Million USD 98.33%
Elanco Animal Health Incorporated -1.23 Billion USD 98.968%
Teva Pharmaceutical Industries Limited -559 Million USD 97.728%
Zoetis Inc. 2.34 Billion USD 100.542%